Pharmaceutical product permissions

A searchable record of what Walter is equipped to evaluate.

Explore compositions across oral solids, oral liquids, sterile injectables, topical formats and selected specialist presentations. Use the catalogue to begin a technical and commercial discussion—not as a substitute for written facility-specific confirmation.

5,500Distinct records
21Dosage forms
407Sterile injectable records
17Therapeutic indexes

Built for portfolio teams

Move from a molecule search to a focused feasibility conversation.

The catalogue brings together composition, strength, pharmacological class, dosage form, manufacturing stream, BCS class and documented regulatory references. It also incorporates products listed in Walter’s March 2025 Injectables Manufacturing Profile. Therapeutic and pharmacological classes are practical navigation labels; final indication, regulatory position and site suitability are confirmed product by product.

Search the catalogue

Selected catalogue briefs

Explore a composition for your manufacturing brief.

Browse selected compositions by dosage form, then share the required strength, pack, quantities and target market for a product-specific feasibility review.

Search the full catalogue
Browse 26 selected composition briefs

Therapeutic index

Begin with the treatment area.

Each composition is assigned to one practical primary area for navigation. Combination products may span more than one clinical use and remain subject to product-specific review.

Searchable permissions catalogue

Find a composition, dosage form or capability route.

5,500distinct permission records

Loading full catalogue search…
Therapeutic area
Dosage-form family
Specific dosage form
Pharmacological class
Manufacturing stream
BCS classification
Confirmed CDSCO category
Drugs Rules status

24 records shown

Pain & musculoskeletal carePRM 0023
Dosage formTablets
Oral

(6S) 5-Methyltetrahydrofolic Acid, Glucosamine Salt (MD)

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Haematinic & nutritional supplement
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Haematology & thrombosisPRM 0077
Dosage formTablets
Oral

Adenosylcobalamin 15 mcg, Ferrous Ascorbate 100 mg, Folic Acid 1.5 mg, Zinc Sulphate 22.5 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Haematinic & nutritional supplement
Manufacturing stream
Non-beta-lactam
BCS class
Class IV (mixed)
CDSCO categoryFDC
Documented match

FDC composition listed in CDSCO approval records

CDSCO filing reference · page 48
Haematology & thrombosisPRM 2155
Dosage formHard-gelatin capsules
Oral

Adenosylcobalamin 500 mcg, Carbonyl Iron 100 mg, Folic Acid 1.5 mg, Zinc Sulphate 22.2 mg

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Haematinic & nutritional supplement
Manufacturing stream
Non-beta-lactam
BCS class
Class IV (mixed)
CDSCO categoryFDC
Documented match

FDC Category C continued-manufacture listing

CDSCO filing reference · page 459
Nutrition & supportive carePRM 0089
Dosage formTablets
Oral

Alpha Lipoic Acid 100 mcg, Calcium Picolinate 200 mg, Methylcobalamin 500 mcg, Pyridoxine 105 mg, Thiamine 2 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Haematinic & nutritional supplement
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Nutrition & supportive carePRM 0090
Dosage formTablets
Oral

Alpha Lipoic Acid 100 mg, Benfotiamine 100 mg, Inositol 100 mg, Methylcobalamin 750 mcg, Pyridoxine 10 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Haematinic & nutritional supplement
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Nutrition & supportive carePRM 2157
Dosage formHard-gelatin capsules
Oral

Alpha Lipoic Acid 100 mg, Benfotiamine 15 mg, Calcium Pantothenate 25 mg, Chromium Picolinate 65 mcg, Folic Acid 1.5 mg, Lutein 5 mg, Methylcobalamin 1500 mcg, Vitamin B6 3 mg, Zinc Oxide 22.5 mg

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Haematinic & nutritional supplement
Manufacturing stream
Non-beta-lactam
BCS class
Class IV (mixed)
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Nutrition & supportive carePRM 2158
Dosage formHard-gelatin capsules
Oral

Alpha Lipoic Acid 100 mg, Benfotiamine 150 mg, Chromium Polynicotinate 200 mcg, Folic Acid 1.5 mg, Inositol 100 mg, Methylcobalamin 1500 mcg, Selenium Dioxide 55 mcg

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Haematinic & nutritional supplement
Manufacturing stream
Non-beta-lactam
BCS class
Class IV (mixed)
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Nutrition & supportive carePRM 0091
Dosage formTablets
Oral

Alpha Lipoic Acid 100 mg, Benfotiamine 150 mg, Chromium Polynicotinate 200 mcg, Folic Acid 1.5 mg, Inositol 100 mg, Methylcobalamin 1500 mcg, Selenium Dioxide Monohydrate 55 mcg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Haematinic & nutritional supplement
Manufacturing stream
Non-beta-lactam
BCS class
Class IV (mixed)
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Nutrition & supportive carePRM 2159
Dosage formHard-gelatin capsules
Oral

Alpha Lipoic Acid 100 mg, Benfotiamine 50 mg, Biotin 5 mg, Chromium 200 mcg, Folic Acid 1.5 mg, Methylcobalamin 1500 mcg, Pyridoxine 3 mg

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Haematinic & nutritional supplement
Manufacturing stream
Non-beta-lactam
BCS class
Class IV (mixed)
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Nutrition & supportive carePRM 2160
Dosage formHard-gelatin capsules
Oral

Alpha Lipoic Acid 100 mg, Benfotiamine 50 mg, Biotin 5 mg, Chromium Picolinate 200 mcg, Folic Acid 1.5 mg, Methylcobalamin 1500 mcg, Vitamin B6 3 mg

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Haematinic & nutritional supplement
Manufacturing stream
Non-beta-lactam
BCS class
Class IV (mixed)
CDSCO categoryFDC
Documented match

Listed in CDSCO FDC approval records

CDSCO filing reference · page 563
Nutrition & supportive carePRM 2161
Dosage formHard-gelatin capsules
Oral

Alpha Lipoic Acid 100 mg, Benfotiamine 50 mg, Chromium Polynicotinate 65 mcg, Folic Acid 0.5 mg, Inositol 100 mg, Methylcobalamin 500 mcg, Selenium Dioxide 18 mcg

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Haematinic & nutritional supplement
Manufacturing stream
Non-beta-lactam
BCS class
Class IV (mixed)
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Nutrition & supportive carePRM 2162
Dosage formHard-gelatin capsules
Oral

Alpha Lipoic Acid 100 mg, Beta Carotene 10.33 mg, Chromium Picolinate 200 mcg, Methylcobalamin 500 mcg, Pyridoxine 1.5 mg, Thiamine 2 mg

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Haematinic & nutritional supplement
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Nutrition & supportive carePRM 2164
Dosage formHard-gelatin capsules
Oral

Alpha Lipoic Acid 100 mg, Folic Acid 1.5 mg, Methylcobalamin 1500 mcg, Pyridoxine 3 mg

Same composition also available as

Tablets

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Haematinic & nutritional supplement
Manufacturing stream
Non-beta-lactam
BCS class
Class IV (mixed)
CDSCO categoryFDC
Documented match

FDC Category C continued-manufacture listing

CDSCO filing reference · page 487
Nutrition & supportive carePRM 0092
Dosage formTablets
Oral

Alpha Lipoic Acid 100 mg, Folic Acid 1.5 mg, Methylcobalamin 1500 mcg, Pyridoxine 3 mg

Same composition also available as

Hard-gelatin capsules

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Haematinic & nutritional supplement
Manufacturing stream
Non-beta-lactam
BCS class
Class IV (mixed)
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Nutrition & supportive carePRM 2165
Dosage formHard-gelatin capsules
Oral

Alpha Lipoic Acid 100 mg, Folic Acid 1.5 mg, Methylcobalamin 1500 mcg, Pyridoxine 3 mg, Thiamine Mononitrate 10 mg

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Haematinic & nutritional supplement
Manufacturing stream
Non-beta-lactam
BCS class
Class IV (mixed)
CDSCO categoryFDC
Documented match

FDC Category C continued-manufacture listing

CDSCO filing reference · page 464
Nutrition & supportive carePRM 2166
Dosage formHard-gelatin capsules
Oral

Alpha Lipoic Acid 100 mg, Folic Acid 1.5 mg, Methylcobalamin 1500 mcg, Pyridoxine 3 mg, Vitamin D3 1000 IU

Same composition also available as

Tablets

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Haematinic & nutritional supplement
Manufacturing stream
Non-beta-lactam
BCS class
Class IV (mixed)
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Nutrition & supportive carePRM 0094
Dosage formTablets
Oral

Alpha Lipoic Acid 100 mg, Folic Acid 1.5 mg, Methylcobalamin 1500 mcg, Pyridoxine 3 mg, Vitamin D3 1000 IU

Same composition also available as

Hard-gelatin capsules

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Haematinic & nutritional supplement
Manufacturing stream
Non-beta-lactam
BCS class
Class IV (mixed)
CDSCO categoryFDC
Documented match

Listed in CDSCO FDC approval records

CDSCO filing reference · page 565
Nutrition & supportive carePRM 0093
Dosage formTablets
Oral

Alpha Lipoic Acid 100 mg, Folic Acid 1.5 mg, Methylcobalamin 1500 mcg, Pyridoxine 3 mg, Zinc Sulphate 15 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Haematinic & nutritional supplement
Manufacturing stream
Non-beta-lactam
BCS class
Class IV (mixed)
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Nutrition & supportive carePRM 2167
Dosage formHard-gelatin capsules
Oral

Alpha Lipoic Acid 100 mg, Folic Acid 1.5 mg, Methylcobalamin 1500 mcg, Vitamin B1 10 mg, Vitamin B6 3 mg

Same composition also available as

Tablets

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Haematinic & nutritional supplement
Manufacturing stream
Non-beta-lactam
BCS class
Class IV (mixed)
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Nutrition & supportive carePRM 0095
Dosage formTablets
Oral

Alpha Lipoic Acid 100 mg, Folic Acid 1.5 mg, Methylcobalamin 1500 mcg, Vitamin B1 10 mg, Vitamin B6 3 mg

Same composition also available as

Hard-gelatin capsules

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Haematinic & nutritional supplement
Manufacturing stream
Non-beta-lactam
BCS class
Class IV (mixed)
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Nutrition & supportive carePRM 2171
Dosage formHard-gelatin capsules
Oral

Alpha Lipoic Acid 100 mg, Methylcobalamin 750 mcg

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Haematinic & nutritional supplement
Manufacturing stream
Non-beta-lactam
BCS class
Class II (mixed)
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Nutrition & supportive carePRM 2172
Dosage formHard-gelatin capsules
Oral

Alpha Lipoic Acid 200 mg, Benfotiamine 10 mg, Biotin 5 mg, Folic Acid 1.5 mg, Methylcobalamin 500 mcg, Pyridoxine 3 mg

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Haematinic & nutritional supplement
Manufacturing stream
Non-beta-lactam
BCS class
Class IV (mixed)
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Nutrition & supportive carePRM 2173
Dosage formHard-gelatin capsules
Oral

Alpha Lipoic Acid 200 mg, Benfotiamine 100 mg, Folic Acid 1.5 mg, Inositol 100 mg, Methylcobalamin 1000 mcg, Pyridoxine 3 mg

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Haematinic & nutritional supplement
Manufacturing stream
Non-beta-lactam
BCS class
Class IV (mixed)
CDSCO categoryFDC
Documented match

Listed in CDSCO FDC approval records

CDSCO filing reference · page 544
Nutrition & supportive carePRM 0102
Dosage formTablets
Oral

Alpha Lipoic Acid 200 mg, Benfotiamine 150 mg, Calcium Citrate Maleate 500 mg, Chromium Polynicotinate 200 mcg, Folic Acid 1.5 mg, Inositol 100 mg, Methylcobalamin 1500 mcg, Pyridoxine 3 mg, Vitamin D3 1000 IU

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Haematinic & nutritional supplement
Manufacturing stream
Non-beta-lactam
BCS class
Class IV (mixed)
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Explore the product catalogue

Browse product pages by therapeutic area.

Browse compositions, strengths and dosage forms for third-party and contract manufacturing enquiries. Each product page includes its catalogue specification, manufacturing and packaging considerations, and a product-specific enquiry link. Confirm the applicable unit, documents and commercial terms with Walter.

How to read this catalogue

Permission is a starting point—not a supply commitment.

01

Therapeutic index

Primary areas provide buyer-friendly navigation. Combination products may reasonably sit across several clinical categories.

02

Facility confirmation

Current licence scope, site allocation, equipment fit and applicable segregation requirements are checked before commitment.

03

Product feasibility

Formula, strength, presentation, pack, target market, testing requirements and commercial scale are assessed together.

04

Responsible use

This B2B catalogue is not prescribing information, patient guidance or a representation that every composition is currently available for sale.

Start the conversation

Found a composition worth discussing?

Use the enquiry link on any record to carry its composition and dosage form into your manufacturing brief.

Request a quote
Quick chat on WhatsAppLet’s discuss your product